Skip to main content
Premium Trial:

Request an Annual Quote

Oxagen CEO is Now Affymetrix s Chief Commercial Officer

NEW YORK, July 24 - Affymetrix has hired Trevor Nicholls to be its first chief commercial officer of global operations, said Affymetrix president, Susan Siegel.

Nicholls, who will be responsible for leading Affy's global sales, marketing, and manufacturing operations, was founder and CEO of Oxagen Limited, a UK-based clinical genomics company. He was replaced at Oxagen earlier this month by Mark Payton, former VP of gene and target portfolio, genetics research at GlaxoSmithKline. When Oxagen announced Payton's appointment on July 10, it said that Nicholls would remain in the CEO post "for some months in order to effect a smooth handover."


Before founding Oxagen, Nicholls served as the commercial director of the life science business of Amersham International.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.